What is Peptide Synthesis? An Introduction to Solid-Phase Peptide Synthesis

September 26, 2026 · By My Store 3 Admin

Peptide synthesis is the chemical process by which peptide chains — sequences of amino acids linked by peptide bonds — are constructed in a controlled laboratory environment. It is a foundational technique in biochemistry and pharmaceutical research, enabling scientists to produce specific peptide sequences for experimental use with a degree of precision and reproducibility that biological extraction cannot reliably achieve.

This article provides an educational overview of peptide synthesis and the dominant production method used for research-grade peptides today: solid-phase peptide synthesis (SPPS).

Why Synthesise Peptides?

Naturally occurring peptides can in principle be isolated from biological sources, but this approach has significant practical limitations: low yields, complex purification requirements, batch-to-batch variability, and the ethical and logistical constraints of working with biological material at scale.

Synthetic production addresses these limitations. By assembling peptide sequences chemically, researchers can:

Produce precise sequences on demand, including sequences that do not occur naturally
Control purity and confirm identity through analytical testing
Generate consistent material across multiple batches
Incorporate non-natural amino acids or isotopic labels for experimental purposes

For research compounds such as BPC-157 and TB-500 — both of which are synthetic peptides derived from or inspired by naturally occurring sequences — chemical synthesis is the standard production method.

Solid-Phase Peptide Synthesis (SPPS)

Solid-phase peptide synthesis was developed by Robert Bruce Merrifield in the early 1960s, work for which he was awarded the Nobel Prize in Chemistry in 1984. It remains the dominant method for producing research-grade peptides today.

The core principle of SPPS is the sequential assembly of a peptide chain while one end is anchored to an insoluble solid support — typically a polymer resin bead. This anchoring simplifies purification between each step, as reagents and by-products can be washed away while the growing peptide chain remains fixed to the resin.

The Basic SPPS Cycle

Peptide chains are assembled from the C-terminus (carboxyl end) to the N-terminus (amino end), one amino acid at a time. Each addition cycle involves three stages:

Deprotection — the protecting group on the resin-bound amino acid's reactive site is removed, exposing it for the next coupling reaction
Coupling — the next amino acid in the sequence, itself protected at its reactive site, is joined to the chain via a peptide bond, facilitated by coupling reagents
Washing — excess reagents and by-products are removed before the next cycle begins

This cycle repeats until the full target sequence has been assembled. The completed peptide chain is then cleaved from the resin and deprotected, releasing the crude peptide in solution.

Fmoc vs Boc Chemistry

Two principal protecting group strategies are used in SPPS:

Fmoc (9-fluorenylmethoxycarbonyl) — the most widely used approach in contemporary research peptide production. Fmoc groups are removed under mild basic conditions (typically piperidine), making the process compatible with a wide range of amino acid side chains and synthesis platforms.
Boc (tert-butyloxycarbonyl) — an older strategy requiring strong acid (hydrogen fluoride) for final deprotection. Less common in modern research settings due to safety and equipment requirements, but still used for certain applications.

The majority of research-grade synthetic peptides produced today, including those supplied for laboratory use, are manufactured using Fmoc SPPS.

Purification and Quality Control

Crude peptide from SPPS typically contains impurities: incomplete sequences (deletion sequences), side-chain modification products, and residual reagents. Purification — most commonly by preparative reverse-phase high-performance liquid chromatography (RP-HPLC) — is required to isolate the target peptide to research-grade purity.

Following purification, analytical quality control confirms both purity and identity:

Analytical HPLC — measures purity as a peak area percentage; research-grade peptides typically require ≥98% purity
Mass spectrometry (MS) — confirms that the observed molecular weight matches the theoretical mass of the target sequence

These results are documented in a Certificate of Analysis (CoA), which provides batch-specific evidence of the compound's identity and quality. For a detailed guide to reading CoA documentation, see: Evaluating Peptide Purity: CoAs, HPLC & What the Data Tells You.

Lyophilisation

Research peptides are typically supplied in lyophilised (freeze-dried) form. Following synthesis and purification, the peptide solution is frozen and subjected to reduced pressure, causing the solvent to sublimate directly from solid to vapour. The result is a stable, dry powder that can be stored at low temperatures with significantly greater long-term stability than a liquid formulation.

Bloom Vitality supplies all research peptides in lyophilised form, with batch-specific CoA documentation available via our Certificates & Documentation page.